Results
1
Mid-Large Cap Stocks
1 companies
Lakefront Biotherapeutics
Market Cap: €1.6b
A biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe.
LKFT
€24.76
7D
0.7%
1Y
1.1%
